Nitric oxide synthase inhibition prevents acute QA-induced neurotoxicity

Acta Veterinaria

Volumn 52, Issue 2-3, 2002, Pages 79-84

  Vasiljević, Ivana ^a   Jovanović, Marina ^a   Ninković, Milica ^a   Malicevic Z ^a  

^a UNIVERSITY OF DEFENCE   (Serbia)

Author keywords

Huntington disease; Nitric oxide; Nitric oxide synthase inhibitors; Quinolinic acid

Indexed keywords

7 NI; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE; QUINOLINIC ACID; SODIUM CHLORIDE;

ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; BRAIN NERVE CELL; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; ENZYME INHIBITION; EPITHELIUM CELL; NEUROTOXICITY; NONHUMAN; RAT;

ANIMALIA; RATTUS NORVEGICUS;

EID: 0036412737     PISSN: 05678315     EISSN: None     Source Type: Journal    
DOI: 10.2298/avb0203079v     Document Type: Article

References (15)

1. Chabrier PE, Demerle-Pallardy C, Auguet M, 1999, Nitric oxide synthases: Targets for therapeutic strategies in neurological diseases. Cell Mol Life Sci, 55(8-9): 1029-35.
2. Dawson T, Dawson V, SnyderS, 1992, A novel neuronal messeger molecule in brain: The free radical, nitric oxide. Ann Neurol, 32: 297-311.
3. Gurd JW, Jones LR, Mahler HR, Moore WJ, 1974, Isolation and partial characterization of rat brain synaptic membrane. J Neurochem, 22: 281-90.
4. Harris CA, Miranda AF, Tanguay JJ, Boegman RJ, Beninger RJ, Jhamandas K, 1998, Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid. Brit J Pharmacol, 124: 391-9.
5. Hirsch EC, Perier C, Orieux G, Francois C, Feger J, Yelnik J et al., 2000, Metabolic effects of nigrostriatal denervation in basal ganglia. Trends Neurosci, 23(10 Suppl): S78-85.
6. Jenner P, 1994, Oxidative Damage in Neurodegenerative Disease. 344: 796-8.
7. Milstien S, Sakai N, Brew BJ, Krieger C, Vickers JH, Saito K, Heyes MP, 1994, Cerebrospinal fluid nitrite/nitrate levels in neurologic diseases. J Neurochem, 63(3): 1178-80.
8. Moroni F, 1999, Trytophan metabolism and brain function: Focus on kynurenine and other indole metabolites. Europ J Pharmacol, 375: 87-100.
9. Perez-Severiano F, Escalante B, Rios C, 1998, Nitric oxide synthase inhibition prevents acute quinolinate-induced striatal neurotoxicity. Neurochem Res, 23(10): 1297-302.
10. Reddy PH, Williams M, Tagle DA, 1999, Recent advances in understending the pathogenesis of Huntingtons disease. Trends Neurosci, 22(6): 248-55.
11. Rodeberg DA, Chaet MS, Bass RC, Arkovitz MS, Garcia VF, 1995, Nitric oxide: An overview. Am J Surg, 170: 292-303.
12. Sathasivam K, Hobbs C, Mangiarini L, Mahal A, Turmaine M, Doherty P et al., 1999, Transgenic models of Huntingtons disease. Philos Trans R Soc Lond B Biol Sci, 354(1386): 963-9.
13. Schmidt W, Woff G, Calka J, Schmidt HH, 1995, Evidence for bidirectional changes in nitric oxide synthase activity in the rat striatum after excitotoxically (quinolinic acid) induced degeneration. Neurosci, 67(2): 345-56.
14. Viinikka L, 1996, Nitric oxide as a challenge for the clinical chemistry laboratory. Scand J Clin Lab Invest, 56: 577-81.
15. Zhang J, Snyder SH, 1995, Nitric oxide in nervous system. Ann Rev Pharmacol Toxicol, 35: 213-33.